First FDA-approved stem cell trial for shoulder injuries reaches full enrollment

First FDA-approved stem cell trial for shoulder injuries reaches full enrollment

The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one's own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.

The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one's own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.

Read More

Read More

  • American Society for Surgery of the Hand
  • American Academy of Orthopaedic Surgeons
  • Healthtap